REST/NRSF governs the expression of dense-core vesicle gliosecretion in astrocytes. by Prada, I. et al.
JCB: Article
The Rockefeller University Press  $30.00
J. Cell Biol. Vol. 193 No. 3 537–549
www.jcb.org/cgi/doi/10.1083/jcb.201010126 JCB 537
Correspondence to Jacopo Meldolesi: meldolesi.jacopo@hsr.it; or Paola Bezzi: 
paola.bezzi@unil.ch
R. D’Alessandro’s present address is Saverio de Bellis Scientific Institute, 70013 
Castellana Grotte Bari, Italy.
Abbreviations used in this paper: BoNT/B, botulinum toxin B; ChgA, chromo-
granin A; ChgB, chromogranin B; CV, clear vesicle; DBD, DNA-binding do-
main; DCV, dense-core vesicle; EPI, epillumination; GFAP, glial fibrillary acidic 
protein; GS, glutamine synthase; mRFP, monomeric RFP; NeuN, neuronal nuclei; 
NPY, neuropeptide Y; RIPA, radioimmunoprecipitation assay; RE-1, restrictive 
element-1; REST, RE-1–silencing transcription factor; RT-PCR, real-time PCR; Sg2, 
secretogranin 2; shRNA, small hairpin RNA; Stx1a, syntaxin 1a; TfR, transferrin 
receptor; TIRF, total internal reflection fluorescence; wtPC12, wild-type PC12.
Introduction
Expression of neurotransmitter-containing vesicles, i.e., small 
clear vesicles (CVs) and dense-core vesicles (DCVs), and their 
Ca2+-induced exocytosis were considered, for long time, to be 
specific properties of neurons and neurosecretory cells (indi-
cated together as nerve cells). However, substantial evidence 
accumulated during the last 15 yr demonstrates that a form of 
exocytic neurotransmitter release, commonly called gliotrans-
mission (Bezzi and Volterra, 2001; Zhang and Haydon, 2005; 
Theodosis et al., 2008), also takes place from a specific type 
of nonnerve cell, the astrocytes of the brain (Volterra and 
Meldolesi, 2005; Haydon and Carmignoto, 2006; Hamilton and 
Attwell, 2010; Parpura and Zorec, 2010), especially at the level 
of the processes enwrapping the pre- and postsynaptic com-
partments of synapses (tripartite synapses; Araque et al., 1999; 
Jourdain et al., 2007; Perea et al., 2009). Consistently, astro-
cytes were found to have a role in complex functions of the ner-
vous system, such as synaptogenesis, plasticity of synapses, 
and circuits, and also behavior (Araque and Navarrete, 2010; 
Halassa and Haydon, 2010; Paixão and Klein, 2010). Formerly 
considered simple scaffold cells, astrocytes are therefore 
recognized as having a much higher rank in the functioning of 
the brain.
In cell biological terms, knowledge of gliotransmission is 
much less detailed than that of neurotransmission. In particular, 
most of the available information refers primarily to CVs. 
Extensive evidence indicates, in fact, that low molecular weight 
Astrocytes are the brain nonnerve cells that are competent for gliosecretion, i.e., for expression and regulated exocytosis of clear and dense-
core vesicles (DCVs). We investigated whether expression 
of astrocyte DCVs is governed by RE-1–silencing tran-
scription factor (REST)/neuron-restrictive silencer factor 
(NRSF), the transcription repressor that orchestrates nerve 
cell differentiation. Rat astrocyte cultures exhibited high 
levels of REST and expressed neither DCVs nor their 
markers (granins, peptides, and membrane proteins). Trans-
fection of a dominant-negative construct of REST induced 
the appearance of DCVs filled with secretogranin 2 and 
neuropeptide Y (NPY) and distinct from other organelles. 
Total internal reflection fluorescence analysis revealed 
NPY–monomeric red fluorescent protein–labeled DCVs 
to undergo Ca2+-dependent exocytosis, which was largely 
prevented by botulinum toxin B. In the I–II layers of the 
human temporal brain cortex, all neurons and microglia 
exhibited the expected inappreciable and high levels of 
REST, respectively. In contrast, astrocyte REST was vari-
able, going from inappreciable to high, and accompa-
nied by a variable expression of DCVs. In conclusion, 
astrocyte DCV expression and gliosecretion are governed 
by REST. The variable in situ REST levels may contribute 
to the well-known structural/functional heterogeneity 
of astrocytes.
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features, including DCVs (Bruce et al., 2006; D’Alessandro 
et al., 2008). Whether REST levels in astrocytes are as high as 
in the other nonnerve cells is unclear. In a pioneer study of the 
rat adult brain, REST mRNA was reported to be as low in astro-
cytes as in neurons (Palm et al., 1998), whereas recently, the 
REST protein was found to be high in rat astrocytes in culture 
(Kohyama et al., 2010). The consequences of these high levels 
in terms of DCV expression were not investigated.
Our evidence, which was obtained by various approaches, 
now demonstrates that in rat astrocyte cultures, the expression 
of DCVs and of their regulated discharge is indeed governed by 
REST. In the standard conditions of our cultures, REST was 
high, and the DCVs together with their markers were almost 
completely lacking. When, however, repression was attenuated 
by transfection of a dominant-negative construct of REST, 
DCVs appeared and were discharged upon stimulation by an exo-
cytic process that was sensitive to botulinum toxin B (BoNT/B). 
In addition, immunocytochemistry of the human brain cortex 
revealed that in situ, the single astrocyte levels of REST are 
variable, from as low as in neurons to as high as in microglia. 
Such heterogeneity, which has never been reported in any type 
of cell, could explain at least part of the conflicting results pre-
viously obtained by different laboratories in terms of DCVs and 
their gliotransmission. In addition, the variable levels of REST 
could play a role in the structural and functional heterogeneity 
of the various forms of astrocytes, a long-known property 
that is still largely unexplained (Volterra and Meldolesi, 2005; 
Oberheim et al., 2006; Wang and Bordey, 2008; Hewett, 2009; 
Matyash and Kettenmann, 2010).
Results
REST and neuro/gliosecretion proteins in 
cultured astrocytes
In view of the conflicting data in the literature (Palm et al., 1998; 
Kohyama et al., 2010), our first purpose was to establish the 
levels and the nuclear/cytoplasmic distribution of REST in 
astrocyte primary cultures grown as described previously (Bezzi 
et al., 2001; Marchaland et al., 2008). As reference models, we 
used two clones of the rat pheochromocytoma PC12 cell line 
transmitters, such as glutamate and d-serine (Bezzi et al., 2004; 
Mothet et al., 2005; Panatier et al., 2006; Jourdain et al., 2007; 
Marchaland et al., 2008; Martineau et al., 2008; Bergersen and 
Gundersen, 2009), accumulate within these vesicles both in cul-
tured astrocytes and in the perisynaptic processes of the hippo-
campus. At the ultrastructural level, CVs have been identified 
(30–80-nm-diameter, round, clear lumen) in the proximity or in 
direct contact with the plasma membrane (Jourdain et al., 2007; 
Bergersen and Gundersen, 2009).
CVs, however, are not the only gliosecretory vesicles. 
Cultured astrocytes investigated by various groups were found 
to contain DCVs that were also recently reported in the human 
brain tissue (Hur et al., 2010). Astrocyte DCVs exhibit the 
typical ultrastructure, which is analogous to the DCVs of nerve 
cells. Moreover, their cargo molecules, i.e., the proteins secreto-
granin 2 (Sg2; Calegari et al., 1999; Paco et al., 2009) and 
secretogranin 3 (Paco et al., 2010), the atrial natriuretic peptide 
(Kreft et al., 2004), and neuropeptide Y (NPY; Ramamoorthy 
and Whim, 2008), and also ATP (Coco et al., 2003; Pangrsic 
et al., 2007) are discharged upon stimulation. The identification 
of the astrocyte DCVs was validated by the characterization of 
their exocytosis (Pangrsic et al., 2007; Ramamoorthy and Whim, 
2008). Yet, in various laboratories, expression of DCVs in astro-
cyte cultures was never demonstrated beyond doubt.
The present study, which was performed in cultures of rat 
astrocytes and in astrocytes of the human brain cortex, investi-
gates the possibility that astrocyte expression of DCVs depends 
on RE-1–silencing transcription factor (REST; otherwise called 
NRSF [neuron-restrictive silencer factor]), the transcription re-
pressor encoded by the master gene that orchestrates differenti-
ation of nerve cells (Ballas and Mandel, 2005; Ooi and Wood, 
2007). A rapid and large decrease of REST, occurring at a late 
nerve cell precursor stage, is known to derepress the transcrip-
tion of hundreds of genes, many of which are specific, and to 
induce the acquisition of multiple aspects of the nerve cell 
phenotype, including DCVs and their exocytosis (Bruce et al., 
2006; D’Alessandro et al., 2008). In contrast, the persistence of 
REST at high levels, which is typical of differentiated nonnerve 
cells (Ballas and Mandel, 2005; Ooi and Wood, 2007), is be-
lieved to preclude the expression of many nerve cell–specific 
Figure 1. Expression and intracellular distribu-
tion of REST in cultured astrocytes and PC12 cell 
clones. (A) The levels of REST mRNA in cultured 
astrocytes that are much higher than those of 
wtPC12 and similar to those of the high REST 
PC12 clone PC12-27. Error bars indicate SEM. 
(B and C) Western blot results concerning the 
225-kD band (C) decorated by the Millipore anti-
REST pAb. Proteomic analyses (to be reported 
elsewhere) demonstrated the 225-kD band to 
contain only REST; other major bands, also deco-
rated by the pAb (not depicted), were shown to 
contain unrelated proteins. The astrocyte REST 
protein levels, 40% of those of PC12-27 cells, 
are shown in B (**, P < 0.01; error bars show SD). 
C shows the REST Western blots of the nuclear 
and cytoplasmic extracts of the three cell types, 
revealing the concentration of the REST protein 
in the nucleus (left) with inappreciable levels in 
the cytoplasm (right). Data are from three experi-
ments performed in triplicate.
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In particular, the SNAP25 mRNA and protein became apprecia-
ble, and those of Stx1a increased slightly, whereas those of Sg2 
increased almost threefold and over sevenfold (Fig. 3, A and C). 
Compared with wtPC12, the Sg2 protein reached a level of 
8% (Fig. 3 C). In contrast, the levels of three astrocyte markers, 
glutamine synthase (GS), glial fibrillary acidic protein (GFAP), 
and S100, remained unchanged (Fig. 3, D and E), confirming 
the bona fide astrocyte nature of the transfected cells.
The effect of REST/DBD-GFP on Sg2 protein expression 
was also clearly visible by immunocytochemistry. In all control 
astrocytes transfected with GFP alone, no Sg2 signal was ap-
preciable (Fig. 4 A). In contrast, >95% of the astrocytes trans-
fected with the REST/DBD-GFP construct exhibited numerous 
puncta that were clearly positive for Sg2, scattered in the cyto-
plasm, and aligned near the plasma membrane (Fig. 4 B). Of these 
puncta, 80% were positive also for endogenous NPY (Fig. 4 C). 
In contrast, when the REST/DBD-GFP–transfected astrocytes 
were dually immunolabeled for Sg2 together with markers of 
intracellular organelles (TGN38 of the TGN, Lamp1 of lysosomes, 
EEA1 of early endosomes, or transferrin receptor [TfR] of late 
endosomes), no colocalization above the background level 
(<5%) was observed in the Sg2-positive puncta (Fig. 4, F–I).
When the REST/DBD-GFP–transfected astrocytes were 
studied by electron microscopy, they exhibited typical DCVs 
(Fig. 4, D and D’) with an mean diameter (corrected as in Parsons 
et al., 1995) of 170 ± 40 nm (n = 32), which were distributed both 
in the depth of the cytoplasm and in the layer adjacent to the plasma 
membrane. These DCVs were intensely immunogold labeled 
for the Sg2 segregated within their lumen. In a few cases, they 
expressing different levels of REST, i.e., a wild-type clone char-
acterized by the low levels typical of nerve cells and a clone 
defective of neurosecretion because of its high levels of the 
transcription repressor (PC12-27; D’Alessandro et al., 2008). 
Fig. 1 A shows that in astrocytes, the REST mRNA (assayed by 
real-time PCR [RT-PCR]) was only slightly lower and much 
higher than those of the PC12-27 and wild-type PC12 (wtPC12) 
clones, respectively. The corresponding REST protein, although 
only 40% of the high REST PC12-27 cells, was still a tenth of 
a fold higher than the wtPC12 (Fig. 1 B). In spite of these dif-
ferences, the intracellular distribution of REST in astrocytes 
and in the two PC12 clones investigated by subcellular fraction-
ation was the same, i.e., almost completely nuclear (Fig. 1 C).
We then investigated the levels of various proteins possi-
bly involved in gliosecretion. Previous studies of these proteins 
in astrocyte cultures had yielded partially conflicting results 
(summarized in Volterra and Meldolesi, 2005). Fig. 2 shows 
that our cultured astrocytes resembled the high REST PC12-27 
clone in their low expression or absence of many proteins typi-
cal of nerve cell DCVs and of their exocytic discharge: the three 
cargo granins chromogranin A (ChgA), chromogranin B (ChgB), 
and Sg2 (Fig. 2 A), two vesicle membrane proteins Syt1 (synap-
totagmin 1) and Syp1 (synaptophysin 1), the t-SNARE SNAP25, 
and the small GTPase Rab3a. Syt4 and Munc18 were also low 
in cultured astrocytes as in high REST PC12-27. However, they 
were closer to the wtPC12 levels. Only the t-SNARE syntaxin 1a 
(Stx1a), although lower than in the wtPC12, was distinctly higher 
in astrocytes than in the high REST PC12-27. Finally, VAMP2, the 
v-SNARE of nerve cell CVs and DCVs, and VAMP3 and SNAP23, 
two SNAREs not involved in neurosecretion but possibly in-
volved in gliosecretion and other membrane fusion processes, 
were expressed at similar or even higher levels in astrocytes and 
high REST PC12-27 than in wtPC12 cells (Fig. 2, B and C). 
The direct role of REST in the repression of at least one of the 
proteins investigated in astrocytes, the t-SNARE SNAP25, 
was confirmed by chromatin immunoprecipitation (Fig. S1).
Transfection of a dominant-negative 
construct of REST induces the expression 
of some gliosecretion genes and 
appearance of DCVs
Cultured rat astrocytes were transiently transfected with 
REST/DNA-binding domain (DBD)–GFP, a dominant-negative 
construct that includes the DBD of REST coupled to GFP 
(D’Alessandro et al., 2008). Previous results with PC12 demon-
strated this construct to compete with the repressor for binding 
to the restrictive element-1 (RE-1) sequence of gene promoters. 
The construct therefore attenuates the specific tone of REST re-
pression (Bruce et al., 2006; Pance et al., 2006; D’Alessandro 
et al., 2008; Klajn et al., 2009). Control astrocytes of these ex-
periments were transfected with the same plasmid that included, 
however, GFP only. Fluorescent cells transfected with either 
GFP alone or REST/DBD-GFP were then sorted out by FACS 
before analysis. Fig. 3 (A–C) shows that among the genes en-
coding proteins typical of nerve cell DCVs or involved in their 
exocytic discharge, the REST/DBD-GFP construct increased 
the expression of only three of them, SNAP25, Stx1a, and Sg2. 
Figure 2. Expression of neuro/gliosecretion proteins in cultured astro-
cytes, in wtPC12, and in high REST PC12-27 cells. (A–C) The figure, repre-
sentative of the results obtained from at least three experiments, illustrates 
the levels of various proteins: cargo proteins (A); vesicle membrane pro-
teins (B); and soluble and t-SNARE proteins (C). Various proteins present 
and even abundant in wtPC12 cells (such as the cargo proteins ChgA, 
ChgB, and Sg2 [A], the vesicle membrane proteins Syt1 and Syp1, Rab3a, 
and the t-SNARE SNAP25 [B and C]) are absent or hardly appreciable 
in astrocytes and PC12-27 cells. Stx1a and Munc18 (C) are low but ap-
preciable. The only proteins well represented in astrocytes and high REST 
PC12-27 are VAMP2, Syt4, VAMP3, and SNAP23 (B and C). The last 
two, which are not directly involved in neurosecretion, may have a role in 
gliosecretion (Volterra and Meldolesi, 2005).
JCB • VOLUME 193 • NUMBER 3 • 2011 540
REST/DBD-GFP was still needed and (b) whether the fluorescent 
peptide was co-distributed with Sg2 in specific puncta spread in the 
superficial cell layer (Marchaland et al., 2008).
The results reported in Fig. 5 validated the use of NPY-
mRFP as a marker of DCV exocytosis. In fact, in 18 out of 19 
control living astrocytes cotransfected with GFP alone, the 
exogenous NPY-mRFP appeared predominantly concentrated 
within thin cisternae apparently spread at random in the cyto-
plasm, which in 13 cells, were accompanied by a few scattered 
puncta of various apparent sizes (100–600 nm; Fig. 5 A). 
TIRF analysis demonstrated that none of these structures were 
included in the evanescent wave illumination layer (Fig. 5 B). 
Moreover, no images of exocytosis were induced when control 
astrocytes transfected with NPY-mRFP were stimulated with 5 µM 
ionomycin (unpublished data). The peculiar distribution of the 
exogenous NPY-mRFP in control astrocytes was not specific in 
the fluorescent peptide because labeled cisternae (accompanied 
in one third of the cells by a few puncta) appeared also in 33 out 
of 33 control astrocytes upon transfection with the DCV mem-
brane protein phogrin coupled to mCherry (Fig. S2 A). Trans-
fection into control astrocytes of Sg2-GFP induced only a weak 
response, which was concentrated in a few discrete puncta 
spread around the nucleus (Fig. S2 C). In this case, the puncta 
were also positive for the vital lysosome marker LysoTracker 
blue (Fig. S2 D), which in contrast, failed to label the DCVs 
induced by transfection of REST/DBD-GFP (not depicted). In 
conclusion, transfection of control astrocytes with fluorescent 
were seen during discharge to the extracellular space (Fig. 4 E). 
We conclude that the attenuation of the endogenous REST tone by 
the transfected REST/DBD-GFP construct induces, in our cultured 
astrocytes, the appearance of bona fide DCVs, which were posi-
tive for the specific markers and analogous to those previously 
reported by others in cultured astrocytes independently of the 
REST/DBD-GFP transfection (Calegari et al., 1999; Kreft 
et al., 2004; Ramamoorthy and Whim, 2008; Paco et al., 2010).
Astrocytes cotransfected with REST/DBD-
GFP and NPY–monomeric RFP (mRFP) 
accumulate DCVs positive for both the 
endogenous Sg2 and the exogenous 
fluorescent peptide
In the data illustrated so far, we reported the appearance of 
DCVs and their endogenous components (Sg2 and NPY) taking 
place in cultured astrocytes upon transfection of the REST 
dominant-negative construct REST/DBD-GFP. To establish 
whether these DCVs were discharged by regulated exocytosis, 
we used total internal reflection fluorescence (TIRF) by which 
the dynamics and discharge of fluorescent puncta (in our case 
DCVs loaded with NPY-mRFP; Ramamoorthy and Whim, 2008) 
is investigated in the 92-nm-thick superficial layer of the cyto-
plasm illuminated by the evanescent wave (Marchaland et al., 
2008). Before carrying out the TIRF experiments, we had to estab-
lish (a) whether transfection of the fluorescent peptide was enough 
to induce the generation of the DCVs or whether cotransfection of 
Figure 3. Expression of neuro/gliosecretion 
proteins in cultured astrocytes transfected with 
GFP or with the dominant-negative construct 
REST/DBD-GFP. (B) Representative Western 
blots illustrating the expression of eleven neuro/
gliosecretion proteins in the two transfected as-
trocyte populations. (A and C) Notice that in 
eight of them, the levels are unaffected by the 
dominant-negative construct, whereas in three, 
Sg2, SNAP25, and Stx1a, gene expression is 
increased at both the mRNA (A) and the protein 
(C) level. Error bars indicate SEM (A) and SD (C). 
*, P < 0.05; **, P < 0.01. (D and E) Trans-
fection of REST/DBD-GFP does not change the 
expression of three astrocyte protein markers, 
GS, GFAP, and S100. Results are from three 
experiments performed in triplicate. Error bars 
indicate SD.
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TIRF analysis confirmed, in the astrocytes cotransfected 
with REST/DBD-GFP and NPY-mRFP, the presence of superfi-
cial NPY-mRFP–positive puncta that are immobile or wonder-
ing around in the cytoplasmic layer illuminated by the evanescent 
wave (Fig. 5 D). Fluorescence of 60% of these puncta occu-
pied from 5 to 8 pixels comparable with the red fluorescence of 
beads 200 nm in diameter (Fig. S3). The latter size is not far 
from the mean diameter of the DCVs measured by electron 
microscopy (Fig. 4 D). Collectively, the results confirm that in 
the REST/DBD-GFP–transfected rat astrocytes, the majority of 
the NPY-mRFP puncta in the evanescent wave illumination 
layer of the cytoplasm correspond to the DCVs positive for en-
dogenous Sg2 and NPY as illustrated in Fig. 4 (B–E).
Astrocyte DCVs are competent for 
regulated exocytosis
TIRF analysis of cultured rat astrocytes doubly transfected 
for REST/DBD-GFP and NPY-mRFP revealed Ca2+-dependent 
regulated exocytosis of NPY-positive DCVs upon addition of 
DCV markers (NPY-mRFP, phogrin-mCherry, and Sg2-GFP) 
induced accumulation within organelles (cisternae, a few puncta, 
and lysosomes) that appear distinct from exocytic DCVs.
The picture changed when astrocytes were transiently co-
transfected with REST/DBD-GFP together with NPY-mRFP. 
In all these cells, mRFP fluorescence was concentrated in dis-
crete puncta, 85% of which were also positive for Sg2, spread 
through the cytoplasm, and also present in the superficial layer of 
the cytoplasm (Fig. 5, C and E). The localization of non-DCV 
organelle markers in the specific NPY-mRFP–labeled small 
puncta was very low (Fig. S2, E–H). The pattern with small 
puncta was not typical of NPY-mRFP only because phogrin-
mCherry–positive puncta predominated when the astrocytes 
were cotransfected with the membrane protein together with 
REST/DBD-GFP (Fig. S2 B). With exogenous NPY, however, 
the immunolabeling was not restricted to the puncta but was 
strong over parallel cisternae and heterogeneous puncta concen-
trated in the Golgi and trans-Golgi areas (Fig. S2, E–H), which were 
positive also for TGN38 and TfR, respectively (Fig. S2, E and H).
Figure 4. Astrocytes transfected with REST/DBD-GFP express DCVs containing Sg2 and NPY. (A and B) Representative confocal images of GFP and 
Sg2 compared in two transfected astrocytes. The control astrocyte (A) transfected with GFP remains negative for Sg2; the astrocyte transfected with the 
REST/DBD-GFP construct (B) also expresses the cargo protein concentrated in small puncta distributed preferentially in the perinuclear area and aligned in 
the proximity of the plasma membrane. (C) Most Sg2-positive puncta of REST/DBD-GFP–transfected astrocytes are also positive for the endogenous secre-
tory peptide NPY. (D and D’) The conventional ultrastructure of DCVs expressed by the REST/DBD-GFP–transfected astrocytes. (E) Three DCVs, one deep 
in the cytoplasm, one adjacent to the surface, and one in the process of being exocytized, all strongly immunogold labeled for Sg2. (F–I) Astrocytes, all 
transfected with REST/DBD-GFP (see their GFP fluorescence in the insets) in which the distribution of Sg2 puncta does coincide only to a background level 
with those of the markers of TGN (TGN38; F), lysosomes (Lamp1; G), early endosomes (EEA1; H), and late endosomes (TfR; I). The images shown are 
representative of results obtained in at least three experiments. Bars: (A and B) 20 µm; (C) 5 µm; (D) 500 nm; (D’ and E) 200 nm; (F–I) 20 µm.
JCB • VOLUME 193 • NUMBER 3 • 2011 542
transfected with REST/DBD-GFP (Fig. 4 and Fig. 5), are also 
present in situ in the tissue astrocytes. Our preliminary ex-
periments of rat brain sections performed by the use of a few 
anti-REST commercial antibodies also used by others for 
immunofluorescence (Shimojo, 2008; Kohyama et al., 2010) 
yielded inconclusive results. The only anti-REST available 
to us that in human brain tissue sections, yielded signals of 
clearly different strength in the various cell types was a rabbit 
pAb obtained from Sigma-Aldrich raised against a peptide 
that was 50% different in the human and rodent RESTs. 
The specificity of this pAb was demonstrated in human NT2 
cells in which REST had been knocked down by transfection 
with a construct containing GFP together with a specific small 
hairpin RNA (shRNA). Fig. S5 A shows that this transfection 
greatly reduced pAb immunolabeling (Sigma-Aldrich) of the 
REST-specific 225-kD Western blot band with respect to control 
NT2 cells transfected with a scrambled RNA–GFP construct. 
5 µM ionomycin. The exocytic process was relatively slow, start-
ing a few seconds after the application of the ionophore, reaching 
its maximum after 100 s, and continuing for ≤7–10 min, with a 
second smaller peak after 230 s (Fig. 6 A). The mean fluorescent 
fusions per cell were 26 ± 3. Fusions were specific because com-
pared with seven control cells, their number decreased by al-
most 80% in five astrocytes pretreated for 2 h with BoNT/B and 
analyzed 20 h later (Fig. S4; Verderio et al., 1999). The fused 
puncta often evolved into fluorescent annuli that faded out within 
500 ms (Fig. 6 B), a typical time course that documents the diffu-
sion of the discharged NPY-mRFP cargo to the extracellular space.
In human brain cortex astrocytes, the 
levels of REST and DCV markers vary  
from very low to high
We next attempted to investigate by immunofluorescence 
whether DCVs, such as those described in cultured astrocytes 
Figure 5. Transfected NPY-mRFP is expressed 
into DCVs only in astrocytes cotransfected with 
REST/DBD-GFP. The insets of all panels show 
the positivity of the cells for GFP (also positive 
for mRFP), documenting that they had been 
transfected with REST/DBD-GFP or the control 
construct. (A and B) In control cells, the distri-
bution of NPY-mRFP is primarily in thin cister-
nae and few puncta (A, deconvolved image), 
which TIRF shows to be largely excluded from 
the surface layer of the cytoplasm illuminated 
by the evanescent wave (B). (C and E) In cells 
cotransfected with REST/DBD-GFP, NPY-mRFP 
is concentrated in scattered discrete puncta 
(C, deconvolved image) and colocalized with 
Sg2 (E, confocal image), corresponding, there-
fore, to the DCVs illustrated in Fig. 4 (D and E). 
The yellow line marks the contours of the cell. 
(D) Small NPY-positive puncta are abundant in 
the surface layer of the cytoplasm illuminated by 
the evanescent wave as illustrated by the TIRF 
image shown. The large fluorescent structures 
of E in the peri-Golgi area are accumulations of 
NPY-mRFP negative for Sg2 (not depicted; also 
see Fig. S2, E–H). The bottom box highlights 
the area of the three panels to the right show-
ing the colocalization of NPY-mRFP and endog-
enous Sg2. A–E are representative of ≥10 cells 
produced in at least three transfection experi-
ments. Bars: (A–E, left) 15 µm; (E, right) 5 µm.
Figure 6. DCVs undergo regulated exocyto-
sis. (A) The temporal distribution of the fusion 
events of NPY-mRFP–positive DCVs in astrocytes 
cotransfected with REST/DBD-GFP and treated 
with 5 µM ionomycin at time 0. Each individ-
ual histogram represents the number of fusion 
events detected during a 200-ms-long frame in 
eight astrocytes. Each point of the black line re-
ports the number of discharge events occurring 
in 10 s. (B) The mean kinetics of the NPY-mRFP 
fluorescence intensity in the course of single-
discharge events (n = 8). Upon fusion, the 
fluorescence of puncta (inner circles) fades out 
with the concomitant increase of fluorescence 
in the external annuli (see scheme on the right), 
which then rapidly dissolve. The image line on 
the bottom illustrates the subsequent steps of 
a typical discharge event. In this line, num-
bers are in milliseconds. Bars: (B, top) 2 µm; 
(B, bottom) 1 µm. A.U., arbitrary unit.
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inappreciable levels of REST were over one third. Those 
exhibiting higher values, which were lower, however, than 
the minimum of microglia, were 15%. In the remaining 
50%, the REST levels were high, spread in the same range 
of microglia (Fig. 7 D).
Additional sections of human cortex tissue were immuno-
stained for Sg2. Unfortunately, no dual Sg2/REST labeling 
could be made because, of the available antibodies against the 
granin, only a rabbit pAb (Calegari et al., 1999) yielded good 
results. In astrocytes, the levels of Sg2 distributed to the 
whole cytoplasm were quite variable (Fig. 8 A, arrow and 
arrowhead), with about half the cells being almost negative 
(Fig. 8 A’’) and the rest showing signals of variable strengths, 
up to clearly positive values (Fig. 8 A’). Other astrocytes that 
were positive for GFAP were coimmunolabeled for NPY and 
REST (sheep and rabbit pAb’s). Fig. 8 B shows that in a cell 
with high REST in the nucleus (Fig. 8 B, arrows), the cyto-
plasmic NPY was low, whereas in two cells with lower levels 
of REST (Fig. 8 B, arrowheads), the NPY signal was stronger. 
A similar inverse correlation was observed in a total of 64 cells. 
However, the NPY data could not be appropriately quanti-
tated because of the presence of strongly positive synapses 
overlapping the astrocyte cytoplasm. Collectively, these data 
suggest that the heterogeneous levels of REST are responsi-
ble, at least in part, for the variable expression of gliosecre-
tion in human astrocytes. The REST/neurosecretion link of 
human astrocytes remains, however, to be characterized in 
further detail.
In rat astrocytes and PC12-27 cells, the Western blot immuno-
decoration with the anti–human REST pAb (Sigma-Aldrich) 
was completely lacking (see the comparison with positive 
human NT2 cells in Fig. S5 B, left), and no nuclear immuno-
labeling was observed in astrocytes of the rat brain cortex 
sections exposed to the same pAb (Fig. S5 B, right). We con-
cluded that this pAb was appropriate to study the distribu-
tion of REST in fragments of the human cortex removed by 
neurosurgery and fixed immediately thereafter but not in cells 
of the rat.
Human brain fragments were first analyzed to validate 
their normal cellular structure. Sections of validated frag-
ments were then investigated by immunofluorescence. In agree-
ment with our subcellular fractionation results in astrocytes, 
PC12 (Fig. 1 C), and other cell types (not depicted), the 
REST of all human brain cells appeared to be concentrated 
almost exclusively in the nucleus. In neurons identified by 
the specific marker, neuronal nuclei (NeuN), the REST sig-
nal was very low or almost inappreciable (Fig. 7 A), whereas 
in microglial cells positive for the marker Iba1, it was strong 
(Fig. 7 B). In astrocytes positive for GFAP, REST immuno-
fluorescence was variable, ranging from almost inapprecia-
ble to as high as in microglia (Fig. 7 C). A quantitative 
analysis of REST fluorescence in single nuclei normalized 
on DAPI fluorescence confirmed that low/inappreciable 
levels were common to all neurons and that the levels of 
microglia ranged from 25 to 100% of the maximal REST/
DAPI ratio observed. Among astrocytes, those showing almost 
Figure 7. Expression of REST in various cell types of the human brain temporal cortex. All images (representative of six slices from two tissue samples) 
are z projections of stacks 8-µm thick. The insets in A and B show the nuclei of all cells present in the panels labeled by DAPI. (A) Neurons labeled by the 
nuclear marker NeuN. Notice in these cells the lack of any appreciable nuclear REST labeling. All the green nuclei of this image belong to NeuN-negative 
nonneuronal cells. (B) Microglial cells immunolabeled in the cytoplasm for the marker Iba1. Notice that in all Iba1-positive cells, nuclei are strongly REST 
positive. (C) The variable expression of REST in the nuclei of astrocytes identified by the cytoplasmic marker GFAP. Some astrocytes exhibit a high REST 
labeling of the nucleus (arrows), whereas in others, the nuclear REST labeling is inappreciable (arrowheads). (C’ and C’’) The areas boxed in C, documenting 
that the astrocyte nuclei present in the image are both positive (arrows) and negative (arrowheads) for REST, were similar in size and in DAPI fluorescence 
intensity. (D) Comparison, in quantitative terms, of the REST fluorescence of single nuclei in the three cell types, normalized to their DAPI fluorescence. The 
anti–human REST antibody used in this figure, in Fig. 8, and in Fig. S5 was the rabbit pAb from Sigma-Aldrich. The red lines mark the mean value of 
the REST/DAPI fluorescence ratios in the three cell types. (A–C’’) Bar, 30 µm.
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to be investigated. In agreement with Kohyama et al. (2010), we 
have found the levels of REST to be high in cultured astrocytes. 
In these cells, therefore, processes dependent on REST should 
all be repressed. Yet, studies from many laboratories, including 
ours (Bezzi et al., 2004; Volterra and Meldolesi, 2005; Domercq 
et al., 2006; Marchaland et al., 2008), had shown cultured astro-
cytes to be fully competent for CV gliosecretion, i.e., to express 
CVs loaded with glutamate and exocytized upon stimulation 
(Haydon and Carmignoto, 2006; Parpura and Zorec, 2010). CV 
gliosecretion may therefore be independent of REST. In con-
trast, the studies of DCVs yielded variable results. The expres-
sion of these vesicles had been reported in cultured astrocytes 
>10 yr ago by Calegari et al. (1999). More recently, DCVs were 
shown to undergo regulated exocytosis, with the release of their 
cargo peptides (atrial natriuretic peptide and NPY) and ATP 
(Kreft et al., 2004; Pangrsic et al., 2007; Ramamoorthy and 
Whim, 2008). However, all astrocytes from the present work, 
which were isolated and cultured according to an established 
procedure (Bezzi et al., 2001), were found to exhibit neither 
DCVs nor their markers. Moreover, when transfected into our 
astrocytes, Sg2-GFP was targeted to lysosomes, whereas NPY-
mRFP and the DCV membrane protein phogrin-mCherry did 
not accumulate primarily in exocytic organelles but in nu-
merous thin cisternae that remain to be identified. A REST 
control of the DCV expression and of their gliosecretion ap-
peared therefore possible.
The first indication that was consistent with this type of 
control came from the characterization of our astrocyte cultures 
that were negative for DCVs, Sg2, and a variety of other pro-
teins involved in neurosecretion, all encoded by genes sensitive 
to REST (D’Alessandro et al., 2008). Only two SNAREs, 
VAMP2 and Stx1a, whose genes are little sensitive to REST 
(D’Alessandro et al., 2008), were expressed in our astrocytes. 
This picture changed when the repressive tone of REST was at-
tenuated by the transient transfection of its dominant-negative 
construct, REST/DBD-GFP, which did not affect the nature of 
the cells documented by three astrocyte markers but induced the 
appearance of DCVs. Interestingly, not all proteins related to 
the organelles increased but only a few. Of the two t-SNAREs, 
Stx1a increased only slightly, whereas SNAP25 increased con-
siderably, remaining, however, at a much lower level (2%) 
compared with wtPC12 cells. Sg2 reached a higher value (8% 
of wtPC12). In PC12-27 cells stably transfected with the REST/
DBD-GFP construct, the same three proteins were also in-
creased. However, the rise of Stx1a was 12-fold, whereas that of 
Sg2 was only twofold (D’Alessandro et al., 2008). These differ-
ences document the cell specificity of the REST control of gene 
expression already reported by Belyaev et al. (2004) and Hohl 
and Thiel (2005).
As previously demonstrated in other cell types (Tooze, 
1998; Day and Gorr, 2003; Huh et al., 2003; Malosio et al., 
2004), the increase of Sg2 appeared necessary, but not suffi-
cient, for the concomitant appearance of astrocyte DCVs, which 
occurred only upon attenuation of the REST tone. In fact, the 
puncta generated upon transfection of the granin alone were not 
DCVs but lysosomes. In contrast, in the cells transfected with 
REST/DBD-GFP, the Sg2-positive puncta distributed, in part, 
Discussion
The role of REST in the expression and regulated exocytosis of 
DCVs had been previously investigated in two nerve cell types 
known to express the organelles, pheochromocytoma PC12 
cells, and brain neurons. In PC12, a strict dependence was dem-
onstrated conclusively (Bruce et al., 2006; D’Alessandro et al., 
2008), and in neurons, it appears quite likely. In fact, various 
proteins involved in DCV composition and discharge are di-
rectly repressed by REST (Schoenherr et al., 1996; Ballas and 
Mandel, 2005; Ekici et al., 2008), whereas others are candidates 
of repression because their genes exhibit, in their regulatory do-
mains, one or a few copies of RE-1, the DNA-binding sequence 
of REST (Bruce et al., 2004; Mortazavi et al., 2006; Otto et al., 
2007). Decreases of REST or expression of truncated forms ac-
companied by expression of a few neurosecretion genes was found 
to also take place in aggressive forms of nonnerve cell tumors of 
the breast, lung, colorectum, and prostate (Coulson, 2005; 
Westbrook et al., 2005; Wagoner et al., 2010). In these tumors, 
however, morphological and functional studies have not been 
performed yet. Whether the expression of neurosecretion markers 
is accompanied or not by the appearance of DCVs discharged 
by regulated exocytosis is, therefore, still unknown.
In astrocytes, the role of REST had been investigated in 
only two recent papers (Abrajano et al., 2009; Kohyama et al., 
2010), neither of which was interested in gliosecretion. Therefore, 
the possibility of a REST dependence for the process remained 
Figure 8. Variable expression of Sg2 and NPY in GFAP-positive astro-
cytes of the human brain temporal cortex. All images are z projections 
of stacks 8 (A and B)- and 4 (A’ and A’’)-µm thick. The inset in A shows 
the DAPI fluorescence of the nuclei in the figure. (A–A’’) The levels of Sg2 in the 
GFAP-positive astrocytes vary considerably from high (arrowhead; see the 
zoom in A’) to low (arrow; see the zoom in A’’). (B) The triple immunolabel-
ing of a few astrocytes identified by their positivity for GFAP that exhibit 
variable levels of REST and NPY (gray). Notice that the cell with high 
REST in the nucleus (arrows) shows a weak NPY signal in the cytoplasm, 
whereas two cells with lower REST (arrowheads) show higher signals for 
the peptide. Bars: (A and B) 30 µm; (A’ and A’’) 5 µm.
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levels rapidly (Guardavaccaro et al., 2008). Depending on their 
signaling state, astrocytes might be able to adjust their expres-
sion of REST with ensuing changes, among other properties, of 
their DCV gliosecretion. Our results for Sg2 and NPY immuno-
labeling might be suggestive in this direction. We found that the 
levels of Sg2 are also variable among astrocytes of the human 
cortex, with 50% looking positive and 50% low or negative 
for the granin. With NPY, we found that cells rich in REST were 
poor in the peptide and vice versa. However, a final demonstra-
tion of this negative correlation will need further dual-labeling 
studies with new antibodies.
In conclusion, our results in astrocytes have shown that 
DCVs and their gliosecretion are expressed under the control of 
REST, apparently at variance with the CVs of the same cells. In 
the human brain cortex, astrocytes exhibit a unique heterogene-
ity in REST expression, ranging from levels as low as those of 
neurons to levels as high as those of microglia. These properties 
should be taken into consideration to explain conflicting results 
reported in the literature in this area. In the expanding frame-
work of astrocyte functions and in view of the key role of REST 
in the expression of hundreds of genes, our results might, ulti-
mately, be useful to explain mechanisms that are operative not 
only in the expression and function of DCVs but also in other 
aspects of brain physiology and, possibly, also of its pathology.
Materials and methods
Reagents and antibodies
The anti-Sg2 rabbit pAb (Calegari et al., 1999) was a gift from P. Rosa 
(National Research Council Institute of Neuroscience, Milan, Italy); BoNT/B 
was a gift from O. Rossetto (University of Padova, Padova, Italy); and 
anti–rat ChgB mAb was developed in our laboratory (Borgonovo et al., 
2002). Other antibodies were obtained from the following sources: anti-
REST and anti-H2b pAb’s were obtained from Millipore; anti-REST mAb 
12C11-1 was a gift from David J. Anderson (California Institute of Technology, 
Pasadena, CA); anti–human REST rabbit HPA006079 pAb, anti GFAP mAb, 
and anti–-tubulin mAb were purchased from Sigma-Aldrich; anti-ChgA 
mAb was purchased from Thermo Fisher Scientific; anti-Rab3a, anti-Stx1a, 
anti-Syt1, anti-Syp, and anti-VAMP2 mAb’s and anti-Munc18, anti-Syt4, 
and anti-SNAP23 rabbit pAb’s were obtained from Synaptic Systems; anti-
SNAP25 mAb was obtained from Covance; anti-S100 rabbit pAb was 
purchased from Dako; anti-NPY sheep pAb, anti-GFAP, anti-NeuN, and 
anti-GS mAb’s were obtained from Millipore; anti-TGN38 mAb was ob-
tained from Thermo Fisher Scientific; anti-Lamp1 and anti-EEA1 mAb’s were 
purchased from BD; anti-TfR mAb was obtained from Invitrogen; anti-
VAMP3 rabbit and anti-Iba1 goat pAb’s were obtained from Abcam; horse-
radish peroxidase–conjugated goat anti–mouse and anti–rabbit pAb’s were 
purchased from Bio-Rad Laboratories; FITC-conjugated anti-GFP pAb 
was obtained from Novus Biologicals; FITC-conjugated, TRITC-conjugated, 
and CY5-conjugated goat anti–mouse and goat anti–rabbit pAb’s were ob-
tained from SouthernBiotech; Alexa fluor 488–conjugated, Alexa fluor 
555–conjugated, and Alexa fluor 647–conjugated goat anti–mouse, goat 
anti–rabbit, donkey anti–mouse, donkey anti–rabbit, and donkey anti–
sheep pAb’s were obtained from Invitrogen; and 15-nm colloidal gold par-
ticles coated with anti–rabbit IgG were obtained from BB International. The 
BCA Protein Assay kit was purchased from Thermo Fisher Scientific; BSA 
was obtained from Roche; Lipofectamine 2000, LysoTracker blue, and 
carboxylate-modified microspheres (FluoSpheres) were purchased from 
Invitrogen; London Resin white was obtained from EMS; PBS was obtained 
from Euroclone; and ionomycin, Epon, DAPI, goat normal serum, donkey 
normal serum, and all other chemicals were purchased from Sigma-Aldrich.
The pAdTrack-CMV-GFP (control-GFP) and the pAdTrack-CMV-REST/
DBD-GFP (REST/DBD-GFP) constructs were gifts from N.J. Buckley (King’s 
College, London, England, UK); the NPY-mRFP construct was a gift from 
R. Regazzi (University of Lausanne, Lausanne, Switzerland); and the Sg2-GFP 
construct was a gift from M. Courel (University of Rouen, Mont-Saint- 
Aignan, France). Rat phogrin (available from GenBank/EMBL/DDBJ under 
near the plasma membrane exhibited the typical ultrastructure 
and a mean diameter (170 nm) within the span of nerve cell 
DCVs. Additional evidence for the DCV nature of these 
organelles included their positivity for an endogenous secre-
tory peptide, NPY, and for a DCV membrane protein, phogrin, 
together with their negativity for markers of the TGN, endo-
somes, and lysosomes.
The final proof for the identification of the Sg2-positive 
puncta as astrocyte DCVs came from the TIRF analysis of the 
cells cotransfected with REST/DBD-GFP and NPY-mRFP. The 
number of puncta scattered in the superficial evanescent wave 
illumination layer of the cytoplasm that were discharged in re-
sponse to the Ca2+ rise was not large (26 per cell on average). 
However, discharge was significant and specific because it was 
largely prevented by pretreatment of the cells with BoNT/B. 
The kinetics of the process was much slower than that of astro-
cyte CVs (Bezzi et al., 2004; Calì et al., 2008) but analogous to 
that previously reported by Pangrsic et al. (2007) studying DCV 
gliosecretion of ATP. Collectively, our data confirm that in as-
trocytes, the expression of DCVs and their discharge are gov-
erned at the transcriptional level by REST, the same factor that 
governs expression of neurosecretion in nerve cells. In our cul-
tured astrocytes, DCV gliosecretion required the REST tone to 
be decreased. Our hypothesis is that a REST tone comparable 
with that of our astrocytes transfected with REST/DBD-GFP is 
present, even without transfection, in the astrocytes cultured in 
other laboratories that were reported to exhibit DCVs.
The heterogeneity of REST levels in human brain tissue 
astrocytes was unexpected. In view of the specificity of the only 
anti-REST pAb that yielded convincing immunocytochemical 
results, our experiments could be performed only in human 
brain cortex fragments removed during neurosurgery. Neurons 
and microglia were found to exhibit different levels of REST: 
the first was very low/inappreciable, and the second was high 
(variability was less than fourfold). In contrast, astrocytes iden-
tified by their marker GFAP did span the whole range of the ob-
served REST values: over one third were as low as neurons, and 
15% was still low but higher than neurons; the remaining 50% 
was as high as the microglia. Heterogeneities in size, shape, recep-
tors, proteins, and, most likely, also function are well-known 
properties of astrocytes (Wilhelm et al., 2004; Volterra and 
Meldolesi, 2005; Oberheim et al., 2006; Wang and Bordey, 
2008; Hewett, 2009; Matyash and Kettenmann, 2010). REST is 
known to repress the transcription of hundreds of target genes 
(Bruce et al., 2004; Mortazavi et al., 2006; Otto et al., 2007), 
however, with different sensitivity (D’Alessandro et al., 2008). 
Moreover, additional effects of the repressor are induced indi-
rectly (Ballas and Mandel, 2005; Ooi and Wood, 2007; Abrajano 
et al., 2009). Therefore, at least some of the astrocyte hetero-
geneities could be caused by differences in their REST levels. 
However, many astrocytes with different phenotypes have a 
specific localization: in the gray and the white matter, the retina, 
the cerebellum, and so on. In the only brain tissue we have in-
vestigated, the human cortex, we have found intermixed astro-
cytes with different REST expression. A reason for this REST 
heterogeneity could be functional. Because of its fast turnover 
(t1/2 = 40 min; Westbrook et al., 2008) REST can change its 
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were precleared with 35 µl protein A–Sepharose-coated beads (Pharmacia) 
in RIPA buffer and split in three. Each aliquot was then incubated overnight 
with 1 µg anti-REST, 1 µg anti-VAMP3 (negative control), or without anti-
bodies (mock controls) in a total volume of 1 ml RIPA buffer. After immuno-
precipitation, the material was treated with 50 µg/ml RNaseA for 
30 min at 37°C and by 500 µg/ml proteinase K in 0.5% SDS at the same 
temperature overnight. Cross-links were reverted by heating the samples at 
65°C for 5 h. The purified DNA was resuspended in 60 µl of distilled 
water, and 6-µl aliquots were used as a template. The chromatin immuno-
precipitation–enriched DNAs of the indicated amplicon (SNAP25) were 
quantified by quantitative PCR in a light cycler (LC480; Roche) using a 
DNA mix SYBR green I kit (FastStart; Roche). The values subtracted of the 
mock values, given in Fig. S1, are means of three separate experiments ± SD. 
For further details see Klajn et al. (2009).
Subcellular fractionation and protein extracts
Total cell extracts were obtained by washing cells in PBS and solubilizing 
them in LB. Samples were rocked at 4°C for 15 min and then centrifuged 
at 13,000 g at 4°C for 15 min to recover the postnuclear supernatant. 
Nuclear and cytoplasmic fractions were separated by gradient centrifugation 
according to Dignam et al. (1983). Cells were washed in PBS, collected by 
scraping on ice, and centrifuged for 5 min at 900 rpm at 4°C. Pellets were 
resuspended in 5 vol buffer A supplemented with 0.3% Triton X-100. After 
30 s of vortexing and centrifugation for 1 min at 11,000 rpm at 4°C, the 
supernatants were added with 1/10 vol buffer B, incubated for 15 min at 
4°C, and centrifuged at 14,000 rpm for 15 min to remove contaminants; 
the pellet was resuspended in 1.6 M sucrose. 300 µl of resuspended nuclei 
were transferred to the bottom of a centrifuge tube and covered with 450 µl 
of 1.5-M sucrose and then with 450 µl of 0.32-M sucrose. After centrifuga-
tion in a swing bucket rotor at 100,000 g for 1 h at 4°C, the pellet was re-
suspended in 20 µl buffer C, incubated for 15 min at 4°C, and centrifuged 
for 15 min at 14,000 rpm to clear the supernatant. Protein concentration 
was determined by the bicinchoninic acid assay.
Western blotting
Equal amounts of proteins (20–50 µg) were separated by SDS-PAGE and 
then transferred to nitrocellulose filters. After blocking for 1 h at RT with 5% 
nonfat dry milk in TBST, the filters were incubated for 2 h at RT or, alterna-
tively, overnight at 4°C with primary antibodies diluted in TBST, 1% BSA, 
and 0.02% sodium azide and then washed five times for 10 min in TBS, 
incubated for 1 h at RT with the appropriate peroxidase-conjugated sec-
ondary antibodies (1 µg/ml) in 5% nonfat dry milk in TBST, and washed 
again in TBST five times for 10 min. Photographic development was by 
chemiluminescence (ECL [GE Healthcare]; Immobilon Substrate [Millipore]). 
Western blot bands were quantified by the ImageJ program (National Insti-
tutes of Health). The data presented, which are expressed as a percentage 
of the corresponding values in wtPC12 cells, are means of at least three 
experiments ± SD.
Living cell image acquisition
Cultured astrocytes cotransfected with either the control-GFP or the REST/
DBD-GFP constructs together with NPY-mRFP, phogrin-mCherry, or Sg2-GFP 
constructs seeded on 24-mm-diameter coverslips were placed in an appro-
priate chamber and incubated in Hepes-KRH at 37°C. Optical sections 
were taken with a 100×/NA of 1.4 Plan Apochromat oil objective (Olympus) 
every 150 nm with a wide-field microscope (IX70; Olympus) equipped 
with an RT Deconvolution system (DeltaVision). Images were acquired with 
a camera (CoolSnap HQ2; Roper Scientific) and deconvoluted with the 
softWoRx Deconvolve software (Applied Precision) to remove the blur in 
fluorescence (as in Borgonovo et al., 2002).
Immunofluorescence of cultured astrocytes
Transfected astrocytes seeded on 24-mm-diameter coverslips were fixed on 
ice for 10 min with 4% paraformaldehyde in PBS. After repeated washes 
in PBS, they were incubated for 1.5 h at RT with primary antibodies in PBS, 
1% BSA, and 0.2% Triton X-100 or 0.4% saponin depending on the anti-
gens. Cells were then extensively washed in PBS, exposed to fluorescent 
conjugated secondary antibodies in PBS and 1% BSA for 1 h at RT, washed 
again, incubated with DAPI for 5 min, and finally, mounted with a reagent 
(FluorSave; EMD). Analyses were performed at RT in a laser confocal 
microscope (TCS SP2; Leica) with a Plan Apochromat 63×/NA of 1.4 oil 
objective. Alternatively, optical sections taken every 150 nm with a wide-
field microscope (IX70) with a RT Deconvolution system were deconvolved 
as in the previous paragraph. Wide-field images were rendered using soft-
WoRx Deconvolve software and ImageJ; confocal images were rendered 
accession no. Z50735) was cloned with EcoRI–AgeI into the pmCherry-N1 
vector (gift from M. Iezzi, University of Lausanne, Lausanne, Switzerland). 
The REST/NRSF target sequence used to design its shRNA was 1,032 
5-ACATGCAAGACAGGTTCACAA-3, which was identified by using an 
RNAi designer algorithm (BLOCK-iT; Invitrogen). The shRNA construct was 
obtained by cloning the 1,032 sequence into pcDNA 6.2-GW/EmGFP-
miR using an RNAi expression vector kit (BLOCK-iT Pol II miR; Invitrogen) 
according to the manufacturer’s instructions. As a negative control, we 
used the pcDNA 6.2-GW/EmGFP-miR-neg plasmid containing a sequence 
targeting any known vertebrate gene. Both plasmids were gifts from D. Pozzi 
(San Raffaele Scientific Institute, Milan, Italy).
Buffers
Lysis buffer (LB) contained 1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 250 mM 
NaCl, 5 mM EDTA, and protease inhibitor cocktail (Sigma-Aldrich). For 
cytoplasmic and nuclear protein extraction, buffer A consisted of 10 mM 
Hepes-KOH, pH 7.8, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and pro-
tease inhibitor cocktail; buffer B consisted of 0.3 M Hepes-KOH, pH 7.8, 
1.4 M KCl, 30 mM MgCl2, and protease inhibitor cocktail; and buffer C 
consisted of 20 mM Hepes-KOH, pH 7.8, 25% glycerol, 0.42 M NaCl, 
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, and protease inhibitor cock-
tail. Sucrose was dissolved in 5 mM Hepes, pH 7.3. TBS with Tween (TBST) 
consisted of 200 mM NaCl, 50 mM Tris, pH 7.4, and 0.05% Tween 20. 
Hepes–Krebs-Ringer Hepes (KRH) contained 120 mM NaCl, 3.1 mM KCl, 
2 mM MgCl2, 1.8 mM CaCl2, 1.25 mM NaH2PO4, 25 mM Hepes-Na, pH 7.4, 
and 4 mM glucose. Radioimmunoprecipitation assay (RIPA) buffer con-
sisted of 1 mM NaEDTA, 0.5 mM NaEGTA, 10 mM Tris-HCl, pH 8, 1% Tri-
ton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 140 mM NaCl, and 
1 mM PMSF. The phosphateglycine buffer was made of phosphate buffer 
and 0.1 M glycine.
Cell cultures
All cells were grown at 37°C in 5% CO2. Primary astrocytes were ob-
tained from 1-d-old Sprague-Dawley rat pups (Charles River and Janvier) 
sacrificed according to procedures approved by the Issues for Institutional 
Animal Care and Use Committees of the San Raffaele Institute and the 
Swiss Federal Veterinary Office. Freshly dissected cerebral cortices were 
disaggregated mechanically, washed, and seeded. After 10–14 d, they 
were depleted of microglial cells by shaking and seeded again for 1–2 d 
in MEM (Sigma-Aldrich) with 10% horse calf serum (PAA Laboratories), 2 mM 
glutamine, 100 U/ml penicillin and streptomycin (PAA Laboratories), and 
0.3% glucose. For further details see Bezzi et al. (2001). Rat pheochromo-
cytoma wtPC12 and PC12-27 clones (as in Borgonovo et al., 2002) were 
grown in DME (Lonza) with 10% horse serum (Euroclone) and 5% fetal 
clone III serum (Hyclone Laboratories) supplemented with 2 mM ultragluta-
mine and 100 U/ml penicillin and streptomycin (Lonza). Human teratoma 
NT2 cells were grown in DME with 10% fetal clone III serum supplemented 
with 2 mM ultraglutamine and 5 U/ml penicillin and streptomycin.
Transfections
Plasmids containing NPY-mRFP, phogrin-mCherry, Sg2-GFP, GFP alone, or 
REST/DBD-GFP (1.8 µg for single transfections; 1 µg each for double trans-
fections) were transfected into primary rat cortical astrocyte cultures by 
Lipofectamine 2000. Cells were analyzed 24–48 h after transfection. In 
some experiments, transfected astrocytes were sorted out from negative 
cells by FACS plus (BD). The shRNA constructs were transfected in human 
NT2 cells by the Lipofectamine 2000 technique.
mRNA isolation and quantitative RT-PCR
Total cellular RNAs extracted according to the RNeasy Mini kit (QIAGEN) 
were used for reverse transcription according to a first-strand synthesis sys-
tem (SuperScript III; Invitrogen). The synthesized cDNAs were templates for 
quantitative PCR (Taqman) performed by the RT-PCR and DNA sequencing 
service of the Istituto Fondazione Italiana Ricerca sul Cancro di Oncologia 
Molecolare–Istituto Europeo di Oncologia Campus for Oncogenomics 
(IFOM-IEO). 18S RNA was used for normalization. Rqmin/Rqmax indi-
cates the SEM (confidence 95%), in which Rqmin/Rqmax is the ratio be-
tween the minimal and maximal relative quantification of a nucleic acid 
sequence in a test sample (Fig 1 A and Fig. 3 A).
Chromatin immunoprecipitation
Astrocyte chromatin was prepared from cultured astrocytes cross-linked 
with 1% formaldehyde for 10 min and then treated with 10 sonication 
cycles of 35 s at 60–70 W (Ultrasonic Processor XL Sonicator; Miosonix), 
each followed by a 2-min rest on ice. Cross-linked chromatin-containing frac-
tions (Klajn et al., 2009) were pooled and stored at 80°C. 20-µg aliquots 
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the coverslip from the high NA objective lens (1.45 NA; -Plan Fluar 
100×; Carl Zeiss). Light entered the coverslip and underwent total internal 
reflection at the glass–cell interface. In our experimental conditions, pene-
tration depth of TIRF illumination was calculated to be 92 nm (Calì et al., 
2008; Marchaland et al., 2008). In the TIRF/EPI illumination imaging pro-
tocol used in our experiments, EPI was generated by a polychromator illu-
mination system (excitation light of 488 nm; Visichrome; Visitron). Once 
the GFP-expressing cell was recognized, TIRF illumination (excitation of 
568 nm) was switched on. The pixel size was 126 nm.
TIRF analysis
The dynamics of individual NPY puncta was studied in TIRF experiments by 
monitoring the mRFP fluorescence in a 1.25-µm-diameter circle positioned 
on top of the spot and in a concentric annulus (inner diameter of 1.25 µm; 
outer diameter of 2.5 µm; Zenisek et al., 2002; Bezzi et al., 2004). Fusion 
events were recognized as the series of stereotyped fluorescence changes 
illustrated in Fig. 6 B; just after the fusion event, the bright mRFP fluores-
cence spread to finally disappear. The temporal distribution of fusion 
events was obtained by plotting them against time. In all experiments, 
counting of fusion events was continued for 600 s from ionomycin appli-
cation. To evaluate the pool of NPY DCVs resident in the evanescent field 
of illumination, cells expressing NPY-mRFP, which were visualized by 568-nm 
TIRF illumination, were manually selected and analyzed for their morphol-
ogy (Fig. 5 E).
Statistical analysis
The significance of differences between pairs of mean values was assessed 
using the two-tailed unpaired t test. P < 0.05 is considered significantly 
different. In the figures, double asterisks indicate P < 0.01, and a single 
asterisk indicates P < 0.05.
Online supplemental material
Fig. S1 demonstrates that in cultured astrocytes, REST is associated to its 
target gene encoding the t-SNARE SNAP25. Fig. S2 demonstrates that the 
transfected DCV membrane protein phogrin-mCherry exhibits a different 
distribution in cultured astrocytes before (cisternae) and after (discrete 
puncta) cotransfection of REST/DBD-GFP. Fig. S3 shows that in REST/DBD-
GFP–transfected astrocytes, the mean radial sweep of the NPY-mRFP–positive 
puncta does not differ from that of red fluorescent beads 200 nm in diame-
ter. Fig. S4 shows that the NPY-mRFP–positive fusions induced in astro-
cytes cotransfected with REST/DBD-GFP by ionomycin are decreased 
>80% upon preincubation with BoNT/B. Fig. S5 shows that the REST West-
ern blot band of human astrocytes is almost completely abrogated upon 
shRNA knockdown of the repressor, documenting the specificity of the 
anti-REST antibody used. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201010126/DC1.
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